Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology announced that two abstracts for its drug Alisertib to be presented at the 2024 ASCO Annual Meeting are now posted on ASCO.org.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks